Enanta Pharmaceuticals reported $321.33M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acorda Therapeutics ACOR:US USD 75.77M 12.14M
Amgen AMGN:US USD 3.65B 1.23B
Anika Therapeutics ANIK:US USD 284.94M 1.22M
Arrowhead Research ARWR:US USD 398.52M 55.41M
AstraZeneca AZN:LN USD 35.13B 798M
Biocryst Pharmaceuticals BCRX:US USD -242659000 29.43M
Biogen BIIB:US USD 12.78B 903M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Clovis Oncology CLVS:US USD -417886000 50.19M
Enanta Pharmaceuticals ENTA:US USD 321.33M 16.69M
Gilead Sciences GILD:US USD 21.06B 821M
GlaxoSmithKline GSK:LN GBP 9.15B 7.22B
Halozyme Therapeutics HALO:US USD 96.99M 196.18M
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Insmed INSM:US USD -29959000 74.2M
Intercept Pharmaceuticals ICPT:US USD 107.68M 477.51M
Karyopharm Therapeutics KPTI:US USD -140280000 23.94M
Ligand Pharmaceuticals LGND:US USD 816.3M 13.93M
Marinus Pharmaceuticals MRNS:US USD 82M 77.2M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Novartis NOVN:VX USD 60.82B 2.1B
Novavax NVAX:US USD -565985000 149.04M
Ptc Therapeutics PTCT:US USD -226904000 44.69M
Sarepta Therapeutics SRPT:US USD 430.84M 295.62M
Vertex Pharmaceuticals VRTX:US USD 13.03B 1.1B
Vital Therapies VTL:US USD 108.81M 19.04M
YTE INCY:US USD 4.23B 141.59M